The median number of BCG doses per patient was 9 in the combination arm and 16 in the monotherapy arm. Phase 3 trial results suggest that adjuvant treatment with mitomycin and bacillus Calmette ...

The median radiographic progression-free survival was not reached in the niraparib arm and was 29.5 months in the placebo arm. Adding niraparib to abiraterone acetate plus prednisone (AAP) and ...

Source: Getty Images Recent studies assessed artificial intelligence (AI) assistance tools in their ability to provide quality medical recommendations for patients. Artificial intelligence (AI) is ...

Health care data breaches that compromised protected health information more than doubled from 2010 to 2024 in the US, data suggest.

Adding zilebesiran to a thiazide diuretic or calcium channel blocker may lead to further blood pressure reduction in patients with uncontrolled hypertension. Zilebesiran added to hypertension ...

Patients with prostate cancer may have a lower risk of recurrence if they take multivitamin supplements after diagnosis, new data suggest.

One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent ...

Only incidence and prevalence rates attributable to keratinocyte cancer, DALYs attributable to BCC would increase by 2050 ...

A prospective study of sex hormone use in patients seeking transgender treatments suggests how these hormones may influence kidney health.

A new study will evaluate the safety and efficacy of universal allogeneic anti-CD19/BCMA CAR T-cells in relapsed or refractory autoimmune diseases including antineutrophil cytoplasmic antibody ...

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes.

We’re probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA and those other journals," Kennedy said.